...
首页> 外文期刊>European journal of cancer care >Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors
【24h】

Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors

机译:在超重和肥胖乳腺癌幸存者中的生活方式干预后,代谢风险,胰岛素抵抗,瘦素和脂蛋的变化

获取原文
获取原文并翻译 | 示例
           

摘要

Abstract Adiposity and physical activity are modifiable factors that could be important determinants of breast cancer ( BC ) prognosis through their effects on endogenous reproductive hormones, chronic inflammation and metabolic changes. Therefore, it is necessary to evaluate whether offering lifestyle interventions to BC survivors could affect the levels of certain biomarkers involved in these mechanisms. We designed a pre–post intervention study offering diet and exercise sessions over 12?weeks to 42 overweight/obese BC survivors. Before and after the intervention, we obtained dietary information, anthropometry and cardiorespiratory fitness ( CRF ) measurements and blood samples to measure metabolic risk, insulin resistance and adipokines biomarkers. Wilcoxon signed‐rank tests and Spearman partial correlation coefficients were used to compare pre‐ and post‐measurements and assess the correlations between changes in biomarkers and changes in anthropometry and CRF . Breast cancer survivors showed significant improvements in metabolic risk biomarkers and insulin resistance indicators along with a non‐significant leptin decrease and a significant adiponectin decrease. The improvements in metabolic risk biomarkers, insulin resistance indicators and leptin were moderately correlated (0.32?≤?| r |?≤?0.55) with the decrease in body mass index and the increase in CRF . Diet and exercise interventions implemented in overweight/obese BC survivors may improve metabolic risk, insulin resistance and leptin biomarkers.
机译:摘要肥胖和身体活动是可修饰的因素,可以是通过对内源生殖激素,慢性炎症和代谢变化的影响来成为乳腺癌(BC)预后的重要决定因素。因此,有必要评估向BC幸存者提供的生活方式干预是否可能影响这些机制中涉及的某些生物标志物的水平。我们设计了一项前进后的干预研究,提供饮食和运动课程超过12个时间,以42个时间超重/肥胖的BC幸存者。在干预之前和之后,我们获得了膳食信息,人体测量和心肺刺激健康(CRF)测量和血液样本,以测量代谢风险,胰岛素抵抗和脂肪因子生物标志物。 Wilcoxon签名秩检验和Spearman部分相关系数用于比较预测和后测量,并评估生物标志物变化与人体测量和CRF的变化之间的相关性。乳腺癌幸存者显示出代谢风险生物标志物和胰岛素抵抗指标的显着改善以及非显着的瘦素下降和显着的脂联素降低。代谢风险生物标志物,胰岛素抵抗指标和瘦蛋白的改善是适度相关的(0.32≤≤1|α≤≤10.55),随着体重指数的降低和CRF的增加。在超重/肥胖的BC幸存者中实施的饮食和运动干预率可能改善代谢风险,胰岛素抵抗和瘦素生物标志物。

著录项

  • 来源
    《European journal of cancer care》 |2018年第4期|共10页
  • 作者单位

    Cancer Prevention and Control ProgrammeCatalan Institute of Oncology (ICO‐IDIBELL)Barcelona Spain;

    Unit of Nutrition and CancerCatalan Institute of Oncology (ICO‐IDIBELL)Barcelona Spain;

    Diabetes and Metabolic Associated Diseases Research GroupRovira i Virgili UniversityTarragona Spain;

    Diabetes and Metabolic Associated Diseases Research GroupRovira i Virgili UniversityTarragona Spain;

    Clinical Nutrition UnitCatalan Institute of Oncology (ICO‐IDIBELL)Barcelona Spain;

    Department of Medical Oncology‐ICOHospital Universitari de Girona Dr. Josep TruetaGirona Spain;

    Breast Cancer Functional UnitCatalan Institute of Oncology (ICO‐IDIBELL)Barcelona Spain;

    Vall d’Hebron Institute of Oncology (VHIO)Hospital Universitari Vall d’HebronBarcelona Spain;

    Vall d’Hebron Institute of Oncology (VHIO)Hospital Universitari Vall d’HebronBarcelona Spain;

    Department of Medical Oncology‐ICOHospital Germans Trias i PujolBarcelona Spain;

    Department of Medical Oncology‐ICOHospital Germans Trias i PujolBarcelona Spain;

    Department of Medical OncologyHospital ClínicBarcelona Spain;

    Department of Medical OncologyHospital del MarBarcelona Spain;

    Department of Medical OncologyConsorci Sanitari de TerrassaTerrassa Spain;

    Department of Physiological Sciences IIUniversity of BarcelonaBarcelona Spain;

    Breast Cancer Functional UnitCatalan Institute of Oncology (ICO‐IDIBELL)Barcelona Spain;

    Breast Cancer Functional UnitCatalan Institute of Oncology (ICO‐IDIBELL)Barcelona Spain;

    Unit of Nutrition and CancerCatalan Institute of Oncology (ICO‐IDIBELL)Barcelona Spain;

  • 收录信息
  • 原文格式 PDF
  • 正文语种 eng
  • 中图分类 肿瘤学;
  • 关键词

    biomarkers; breast cancer; physical activity; survivors; weight control;

    机译:生物标志物;乳腺癌;身体活动;幸存者;体重控制;

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号